Finally, one patient carrying the G908R NOD2 variant, presented with a clinical syndrome resembling Crohn’s disease, albeit he was refractory to anti-TNFa treatment and showed good response to anti-IL-1 agents, and another one had relapsing urticaria refractory to steroids, periorbital swelling, and increased inflammatory markers. The gene discussed is NOD2; the disease is urticaria.